ArticleRheumatology and immunology research2020

Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience.

Laura Cometi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.